Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,582 shares at $301.84 ($1.1M) on 2022-10-18, disclosed to the SEC on 2022-10-20.
Open-market sale of $1.1M VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.02 | 1,503 | $451K | 41.9% |
| 2 | $300.02 | 1,503 | $451K | 41.9% |
| 3 | $301.84 | 288 | $87K | 8.1% |
| 4 | $301.84 | 288 | $87K | 8.1% |
| Total | $300.31 avg | 3,582 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |